Form DRS/A - Draft Registration Statement: [Amend]
SEC Accession No. 0000912057-16-000481
Filing Date
2016-01-19
Accepted
2016-01-19 06:50:45
Documents
24

Document Format Files

Seq Description Document Type Size
1 filename1.htm DRS/A 2265929
2 filename2.htm EX-4.2 362551
3 filename3.htm EX-10.2 291113
4 filename4.htm EX-10.12 17298
5 filename5.htm EX-10.13 16921
6 filename6.htm EX-10.14 16865
7 filename7.htm EX-10.15 140900
8 filename8.htm EX-10.16 188660
9 filename9.htm EX-10.17 30150
10 g197595.jpg GRAPHIC 35644
11 g251333.jpg GRAPHIC 76270
12 g342833.jpg GRAPHIC 12219
13 g363356.jpg GRAPHIC 29096
14 g419181.jpg GRAPHIC 46733
15 g492034.jpg GRAPHIC 82080
16 g612051.jpg GRAPHIC 56098
17 g640635.jpg GRAPHIC 60258
18 g667216.jpg GRAPHIC 368
19 g684562.jpg GRAPHIC 82357
20 g727555.jpg GRAPHIC 124258
21 g830084.jpg GRAPHIC 169926
22 g864922.jpg GRAPHIC 54417
23 g943928.jpg GRAPHIC 75058
24 g1031628.jpg GRAPHIC 58535
  Complete submission text file 0000912057-16-000481.txt   4659525
Mailing Address 43334 7 MILE ROAD SUITE 1000 NORTHVILLE MI 48167
Business Address 43334 7 MILE ROAD SUITE 1000 NORTHVILLE MI 48167 248-980-6538
Gemphire Therapeutics Inc. (Filer) CIK: 0001638287 (see all company filings)

EIN.: 472389984 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DRS/A | Act: 33 | File No.: 377-01152 | Film No.: 161346915
SIC: 2834 Pharmaceutical Preparations